NCT07824687Completed
Effect of Mindful Breathing in Patient With Heart Failure:
Effect of Mindful Breathing on Symptom Status and Clinical Parameters in Patient With Heart Failure : A Randomized Controlled Trail
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
The aim of this study was to investigate the effect of mindful breathing on symptom status and clinical parameters in patients with heart failure. This randomized controlled trial was conducted with a total 64 patients who randomly allocated to receive 64 HF patients. Stratified block randomization was used for randomization according to New York Heart Association classification heart failure (NYHA Stage II -III). Patients in the intervention group (n=32) performed mindful breathing for 20 minutes daily for 8 weeks. The control group (n=32) received routine treatment. The Heart Failure Symptom Status Scale was administered face-to- face to both groups on 0th day, at 8th and 12th weeks. Routine clinic evaluations included low-density lipoprotein, high-density lipoprotein, total cholesterol, and triglyceride levels assessed on 0th day, at 8th and 12th weeks. Ejection fraction values were accessed from the hospital data system on 0th day at the 8th week. The data were analyzed using IBM SPSS V23 and JAMOVI software.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 64 (actual)
- First submitted
- 9 Feb 2025
- Start date
- 10 Oct 2023
- Primary completion date
- 10 Apr 2024
- Lead sponsor
- Ankara Medipol University
- Diseases
- Heart failure
- NCT number
- NCT07824687
What you commit to
- Study type: Interventional
- Participants enrolled: 64
- From 10 Oct 2023 to the primary completion date, 10 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently using non-pharmacological treatments such as herbal medicine, meditation, or yoga
Other illness
- Diagnosed with NYHA Stage I or IV heart failure
- Having physical or mental conditions that impair communication
- Having health conditions that prevent breath awareness exercises (e.g., advanced asthma, advanced COPD)
Who the study is looking for
- Diagnosed with NYHA Stage II or III heart failure
- Have experienced heart failure symptoms
- Aged 18 years or older
- Able to read and write in Turkish
- Able to use a smartphone, respond to daily researcher calls, and participate in WhatsApp video conferences
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Health Sciences University Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.